Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

118
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
118
One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation01:24

One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation

659
This lesson introduces two critical methods in pharmacokinetics, the Wagner-Nelson and Loo-Riegelman methods, used for estimating the absorption rate constant (ka) for drugs administered via non-intravenous routes. The Wagner-Nelson method relates ka to the plasma concentration derived from the slope of a semilog percent unabsorbed time plot. However, it is limited to drugs with one-compartment kinetics and can be impacted by factors like gastrointestinal motility or enzymatic degradation.
On...
659
Mechanistic Models: Compartment Models in Algorithms for Numerical Problem Solving01:29

Mechanistic Models: Compartment Models in Algorithms for Numerical Problem Solving

98
Mechanistic models play a crucial role in algorithms for numerical problem-solving, particularly in nonlinear mixed effects modeling (NMEM). These models aim to minimize specific objective functions by evaluating various parameter estimates, leading to the development of systematic algorithms. In some cases, linearization techniques approximate the model using linear equations.
In individual population analyses, different algorithms are employed, such as Cauchy's method, which uses a...
98
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis00:59

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

111
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
111
Model Approaches for Pharmacokinetic Data: Compartment Models01:14

Model Approaches for Pharmacokinetic Data: Compartment Models

173
Compartmental analysis is a widely adopted approach to characterizing drug pharmacokinetics. It uses compartment models that conceptualize the body as a collection of reversibly communicating compartments, each representing a group of tissues exhibiting similar drug distribution characteristics. The movement rate of the drug between these compartments is typically described by first-order kinetics.
Two primary types of compartment models are recognized: mammillary and catenary. The more...
173
Compartment Models: Single-Compartment Model01:14

Compartment Models: Single-Compartment Model

2.4K
The single-compartment model serves as a simplified representation of the human body. This model assumes that the body functions as a single, well-mixed open compartment. When a drug is administered intravenously, it enters the body and quickly distributes uniformly. The drug then undergoes biotransformation and elimination, ultimately leaving the body. The volume of this compartment is referred to as the apparent volume of distribution into which the drug can uniformly distribute. In this...
2.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

PK and PK/PD Modeling of Bcl2 Inhibitor S65487 in Patients With AML and Investigation of Nonlinearity With Microdosing.

CPT: pharmacometrics & systems pharmacology·2026
Same author

PKPD-Based Translational Modeling of Calaspargase Pegol Preclinical Activity in Hepatocellular Carcinoma.

European journal of drug metabolism and pharmacokinetics·2026
Same author

Cross-species comparison of platelet proteomes reveals developmentally regulated metabolic and inflammatory changes.

Blood vessels, thrombosis & hemostasis·2026
Same author

PK-PD Modeling Suggests Tumor Heterogeneity Limits Preclinical to Clinical Translation of Enzalutamide in Prostate Cancer.

Pharmaceutical research·2026
Same author

Hybrid Systems Modeling of Donor T-Cell Responses and Graft-Versus-Host-Disease After Posttransplantation Cyclophosphamide Administration.

CPT: pharmacometrics & systems pharmacology·2026
Same author

Shared and distinct effects of mood stabilizers on epigenetic machinery gene expression: an exploratory study in HeLa cells.

European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology·2026

Related Experiment Video

Updated: Aug 23, 2025

Author Spotlight: Development of an Automated Camera-Based System for Real-Time Blast Overpressure Monitoring and TBI Risk Assessment in Military Training
06:20

Author Spotlight: Development of an Automated Camera-Based System for Real-Time Blast Overpressure Monitoring and TBI Risk Assessment in Military Training

Published on: December 6, 2024

2.9K

Accelerating robust plausible virtual patient cohort generation by substituting ODE simulations with parameter space

Thibaud Derippe1,2,3, Sylvain Fouliard1, Xavier Declèves2

  • 1Institut de Recherches Internationales Servier, Suresnes, France.

Journal of Pharmacokinetics and Pharmacodynamics
|November 1, 2022
PubMed
Summary

This study introduces a new method to speed up the creation of virtual patients (VPs) for quantitative systems pharmacology (QSP) by using parameter patterns. This approach significantly reduces the time needed to identify plausible VPs, accelerating drug development simulations.

Keywords:
PK/PD modelsQuantitative systems pharmacologyVirtual patient simulationsVirtual population

More Related Videos

Modeling and Simulations of Olfactory Drug Delivery with Passive and Active Controls of Nasally Inhaled Pharmaceutical Aerosols
15:04

Modeling and Simulations of Olfactory Drug Delivery with Passive and Active Controls of Nasally Inhaled Pharmaceutical Aerosols

Published on: May 20, 2016

11.0K
Targeting Neuronal Fiber Tracts for Deep Brain Stimulation Therapy Using Interactive, Patient-Specific Models
14:14

Targeting Neuronal Fiber Tracts for Deep Brain Stimulation Therapy Using Interactive, Patient-Specific Models

Published on: August 12, 2018

9.0K

Related Experiment Videos

Last Updated: Aug 23, 2025

Author Spotlight: Development of an Automated Camera-Based System for Real-Time Blast Overpressure Monitoring and TBI Risk Assessment in Military Training
06:20

Author Spotlight: Development of an Automated Camera-Based System for Real-Time Blast Overpressure Monitoring and TBI Risk Assessment in Military Training

Published on: December 6, 2024

2.9K
Modeling and Simulations of Olfactory Drug Delivery with Passive and Active Controls of Nasally Inhaled Pharmaceutical Aerosols
15:04

Modeling and Simulations of Olfactory Drug Delivery with Passive and Active Controls of Nasally Inhaled Pharmaceutical Aerosols

Published on: May 20, 2016

11.0K
Targeting Neuronal Fiber Tracts for Deep Brain Stimulation Therapy Using Interactive, Patient-Specific Models
14:14

Targeting Neuronal Fiber Tracts for Deep Brain Stimulation Therapy Using Interactive, Patient-Specific Models

Published on: August 12, 2018

9.0K

Area of Science:

  • Pharmacology
  • Computational Biology
  • Systems Biology

Background:

  • Quantitative systems pharmacology (QSP) workflows rely on generating virtual patients (VPs).
  • Traditional VP generation involves time-intensive ordinary differential equation (ODE) solving.
  • Current methods often produce non-physiological outputs, necessitating extensive acceptance/rejection steps.

Purpose of the Study:

  • To develop a novel approach for accelerating VP generation in QSP.
  • To reduce computational time associated with ODE solving and VP filtering.
  • To leverage parameter-output associations for efficient VP selection.

Main Methods:

  • Developed algorithms that exploit monotonic relationships between model parameters and outputs of interest (OoI).
  • Used parameter value comparisons to replace ODE-solving steps for VP acceptance/rejection.
  • Tested algorithms on tumor growth inhibition and apoptosis QSP models.

Main Results:

  • The new method significantly reduced VP analysis time compared to a reference approach.
  • Analysis of 200,000 VPs in a tumor growth model decreased from 50s to 3-41s.
  • Characterization of VPs for an apoptosis model with four drug regimens was reduced from over 80 min to 12 min.

Conclusions:

  • The developed algorithms efficiently extract plausible VPs by utilizing parameter-output monotonicity.
  • This approach offers substantial time savings and flexibility in QSP modeling.
  • The method accelerates the identification of virtual patient phenotypes, aiding drug discovery and development.